Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The evolutionary scenario of hepatocellular carcinoma in Italy: an update

Title: The evolutionary scenario of hepatocellular carcinoma in Italy: an update
Authors: Bucci L.; Garuti F.; Lenzi B.; Pecorelli A.; Farinati F.; Giannini E. G.; Granito A.; Ciccarese F.; Rapaccini G. L.; Di Marco M.; Caturelli E.; Zoli M.; Borzio F.; Sacco R.; Camma C.; Virdone R.; Marra F.; Felder M.; Morisco F.; Benvegnu L.; Gasbarrini A.; Svegliati-Baroni G.; Foschi F. G.; Missale G.; Masotto A.; Nardone G.; Colecchia A.; Bernardi M.; Trevisani F.
Contributors: Bucci, L.; Garuti, F.; Lenzi, B.; Pecorelli, A.; Farinati, F.; Giannini, E. G.; Granito, A.; Ciccarese, F.; Rapaccini, G. L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Sacco, R.; Camma, C.; Virdone, R.; Marra, F.; Felder, M.; Morisco, F.; Benvegnu, L.; Gasbarrini, A.; Svegliati-Baroni, G.; Foschi, F. G.; Missale, G.; Masotto, A.; Nardone, G.; Colecchia, A.; Bernardi, M.; Trevisani, F.
Publication Year: 2017
Collection: Archivio della ricerca dell'Università di Modena e Reggio Emilia (Unimore: IRIS)
Subject Terms: epidemiology; hepatocellular carcinoma; survival; treatment; Adult; Age Distribution; Aged; 80 and over; Carcinoma; Hepatocellular; Catheter Ablation; Databases; Factual; Female; Human; Italy; Liver Neoplasm; Male; Middle Aged; Neoplasm Staging; Prognosi; Retrospective Studie; Sex Distribution; Young Adult; alpha-Fetoproteins
Description: Background & Aims: Epidemiology of hepatocellular carcinoma is changing worldwide. This study aimed at evaluating the changing scenario of aetiology, presentation, management and prognosis of hepatocellular carcinoma in Italy during the last 15years. Methods: Retrospective analysis of the ITA.LI.CA (Italian Liver Cancer) database including 5192 hepatocellular carcinoma patients managed in 24 centres from 2000 to 2014. Patients were divided into three groups according to the date of cancer diagnosis (2000–2004, 2005–2009 and 2010–2014). Results: The main results were as follows: (i) progressive patient aging; (ii) progressive expansion of non-viral cases and, namely, of “metabolic” hepatocellular carcinomas; (iii) increasing proportion of hepatocellular carcinoma diagnosed during a correct (semi-annual) surveillance programme; (iv) favourable cancer stage migration; (v) increased use of radiofrequency ablation to the detriment of percutaneous ethanol injection; (vi) improved outcomes of ablative and transarterial treatments; (vii) improved overall survival (adjusted for the lead time in surveyed patients), particularly after 2009, of both viral and non-viral patients presenting with an early- or intermediate-stage hepatocellular carcinoma. Conclusions: During the last 15years several aetiological and clinical features of hepatocellular carcinoma patients have changed, as their management. The observed improvement of overall survival was owing both to the wider use of semi-annual surveillance, expanding the proportion of tumours that qualified for curative treatments, and to the improved outcome of loco-regional treatments.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/27427866; info:eu-repo/semantics/altIdentifier/wos/WOS:000393771900012; volume:37; issue:2; firstpage:259; lastpage:270; journal:LIVER INTERNATIONAL; https://hdl.handle.net/11380/1280933
DOI: 10.1111/liv.13204
Availability: https://hdl.handle.net/11380/1280933; https://doi.org/10.1111/liv.13204
Rights: info:eu-repo/semantics/closedAccess
Accession Number: edsbas.51723024
Database: BASE